10,112名患有真多细胞血症的患者的治疗模式和血清控制
Naveen Pemmaraju1, Jingbo Yu2, Anupama Vasudevan3
1The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Expert review of hematology
|June 13, 2025
概括
在多细胞真血症 (PV) 中,初步治疗,如瘤手术和氨酸尿素 (HU),往往无法控制血细胞计数. 在一项现实研究中,切换到ruxolitinib显著改善了血红素控制和减少了瘤手术的需要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 内部医学 内部医学
背景情况:
- 在多细胞血症 (PV) 中血细胞计数升高与血栓形成风险增加有关,有助于显著的发病率和死亡率.
- 有效地管理PV对于改善患者的治疗结果和减少与疾病相关的并发症至关重要.
研究的目的:
- 描述治疗模式和评估PV患者的血细胞计控制.
- 在现实环境中评估初始治疗与替代疗法的有效性.
主要方法:
- 对10,112名PV患者的回顾性分析.
- 2014年1月至2023年2月期间从社区瘤实践中收集的数据.
- 评估治疗模式,包括瘤切除术,氧尿素 (HU) 和 ruxolitinib,以及它们对血红素和血液计数的影响.
主要成果:
- 大多数患者最初接受了神经切除术 (68.1%) 或HU (28.2%).
- 一年后,高比例的切术 (67.8%) 和HU (30.4%) 患者血红素水平升高.
- 与HU相比,从HU切换到ruxolitinib的结果是85.4%的血液值达到<45%的水平,并且与HU相比减少了瘤切除的需求 (29.3%与53.5%相比).
- 卢克索利提尼布治疗也导致白细胞和血小板数量的改善.
结论:
- 对于PV的初始治疗方案可能并不总是达到足够的血清控制.
- 鲁克索利提尼布在改善PV患者的血红素控制和其他血液参数方面表现出显著的有效性.
- 现实世界的证据支持在初始治疗不足时考虑像鲁克索利提尼布这样的替代疗法.
相关概念视频
Disorders of Erythrocytes
903
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
903
Factors Affecting Erythropoiesis
3.2K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.2K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
147
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
147
Erythropoiesis
4.1K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.1K
Esophageal Varices-II: Clinical Features and Management
51
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
51
Disorders of Leukocytes
910
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
910


